CD200 expression can be observed in various hematopoietic cancers, including acute myeloid leukemia (AML), as well as in certain diseases derived from B lymphocytes, such as chronic lymphocytic leukemia (CLL) and hairy cell leukemia (HCL) [101]. Here, CD200 is linked to hairy cell leukemia.